This Lead and Inform Clinical Reference Group (CRG) covers specialised treatment of certain immunological and allergic conditions. Scope This clinical reference group covers: Immunological conditions including: primary immunodeficiencies autoimmune and autoinflammatory disease where there is associated immunodeficiency complex autoimmune and vasculitic conditions autoinflammatory syndromes Allergic conditions including severe, complex and/or rare sub-groups. Membership Dr Claire […]

Rapid policy statement Publications approval reference: C1712 Contents Commissioning position Evidence and policy summary Implementation Governance Equality statement Definitions References Publication date: 28 November 2022 Effective from: 28 November 2022 Commissioning position Tocilizumab is recommended to be available as a treatment option through routine commissioning for adult patients (aged 18 years and older) hospitalised with […]

Child Immunisation Q1 – Q4 2014/15 Today NHS England published the latest experimental management information relating to Child Immunisation data for Q1 – Q4 2014/15. The data includes: DTaP/IPV/Hib – 12 month & 24 month MenC Primary – 12 month, 24 month & 5 year Hib Primary – 5 year PCV primary – 12 month […]

This section contains information on the total number of COVID-19 therapeutics (antivirals – ‘AVs’, neutralising monoclonal antibodies – ‘nMABS’, and interleukin 6 – ‘IL-6’ inhibitors) provided by the NHS in England to: Eligible individuals hospitalised due to COVID-19, or with hospital-onset COVID-19 in England. Eligible non-hospitalised individuals in England with COVID-19 since AVs and nMABs […]

Contents Actions now required Annex A – JCVI list of eligible individuals Annex B: Template letter to severely immunosuppressed individuals for GP practices and consultants to adapt and issue Annex C – Template letter for consultants (to be put on consultant / GP letterhead)   Classification: Official Publication approval reference: C1399 To: All GP practices […]

Today NHS England published the latest experimental management information relating to Child Immunisation data for Q3 2014/15. The data includes: • DTaP/IPV/Hib – 12 month & 24 month • MenC Primary – 12 month, 24 month & 5 year • Hib Primary – 5 year • PCV primary – 12 month & 5 year • […]

Today NHS England published the latest statistical information relating to Child Immunisation data for Q1 – Q3 2013/14. The data includes: • DTaP/IPV/Hib – 12 month & 24 month • MenC Primary – 12 month, 24 month & 5 year • Hib Primary – 5 year • PCV primary – 12 month & 5 year […]

Today NHS England published the latest experimental management information relating to Child Immunisation data for Q1 2014/15. The data includes: • DTaP/IPV/Hib – 12 month & 24 month • MenC Primary – 12 month, 24 month & 5 year • Hib Primary – 5 year • PCV primary – 12 month & 5 year • […]

Today NHS England published the latest experimental management information relating to Child Immunisation data for Q1 2015/16. The data includes: • DTaP/IPV/Hib – 12 month & 24 month • MenC Primary – 12 month, 24 month & 5 year • Hib Primary – 5 year • PCV primary – 12 month & 5 year • […]

Contents Immediate action required Annex A – JCVI List of eligible individuals   Classification: Official Publication approval reference: C1428 To: All NHS trust and foundation trust chief executives All NHS trust and foundation trust medical directors CC: CCG accountable officers ICS leads PCN-led vaccination sites Regional Directors Regional Directors of Commissioning   Dear colleague On […]